Launch week offerEnds in00h00m00s

annual Promonthly Pro

Jean-Baptiste Bachet

Head of digestive oncology unit

Sorbonne Université

France

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in France Professors in Biostatistics Biostatistics professors in France

Articles (12)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (8)

Qian Shi

Mayo Clinic

UNITED STATES

View details

Timothy J. Price

Head of Haematology and Oncology Unit

Queen Elizabeth Hospital

AUSTRALIA

View details

Richard Adams

Professor

Cardiff University

UNITED KINGDOM

View details

Maximiliano Gelli

Chief of Department, HPB Surgeon

Institut Gustave Roussy

FRANCE

View details

Eric Van Cutsem

BELGIUM

View details

Yohann Foucher

Professor

FRANCE

View details

Pierre Laurent-Puig

Université Paris Descartes

FRANCE

View details

Lilian SCHWARZ

Marie and Louis Pasteur University

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jean-Baptiste Bachet

Research Interests

Make your next move.

Explore related searches

Articles (12)

Reproducibility of overall survival in metastatic colorectal cancer randomized trials using ARCAD-derived external control arms

Netrin1 blockade alleviates resistance to chemotherapy in pancreatic cancer

Reply to: Random Assignment, But Without Comparison: A Missed Opportunity

Neoadjuvant FOLF(IRIN)OX Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Multicenter Randomized Noncomparative Phase II Trial (PANACHE01 FRENCH08 PRODIGE48 study)

Characteristics of Patients and Prognostic Factors Across Treatment Lines in Metastatic Colorectal Cancer: An Analysis From the Aide et Recherche en Cancérologie Digestive Database

Predictive and prognostic factors of efficacy of third-line chemotherapy in patients with unresectable pancreatic cancer: a cohort-based study

Prognostic Models From Transcriptomic Signatures of the Tumor Microenvironment and Cell Cycle in Stage III Colon Cancer From PETACC-8 and IDEA-France Trials

PRODIGE 29-UCGI 26 (NEOPAN): A Phase III Randomized Trial Comparing Chemotherapy With FOLFIRINOX or Gemcitabine in Locally Advanced Pancreatic Carcinoma

Clinical and quality of life outcomes with trifluridine/tipiracil: PRECONNECT and TALLISUR studies

Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: final results from the phase IIIb single-arm PRECONNECT study by duration of therapy

Trop-2 is a ubiquitous and promising target in pancreatic adenocarcinoma

Additional file 1 of Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: final results from the phase IIIb single-arm PRECONNECT study by duration of therapy

Collaborators (8)

Qian Shi

Timothy J. Price

Richard Adams

Maximiliano Gelli

Eric Van Cutsem

Yohann Foucher

Pierre Laurent-Puig

Lilian SCHWARZ

Make your next move.